Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Perkins KA. Acute nicotine reinforcement requires ability to discriminate the stimulus effects of nicotine. Experimental and Clinical Psychopharmacology. Forthcoming. doi: 10.1037/pha0000433.
Karelitz JL, Perkins KA. Acute subjective sensory perceptions predict relative reinforcing effects of smoked nicotine. Addict Behav. 2021 Jun;117:106835. doi: 10.1016/j.addbeh.2021.106835. Epub 2021 Jan 15. PubMed PMID: 33517233; PubMed Central PMCID: PMC7956130.
Perkins KA. Acute nicotine reinforcement requires ability to discriminate the stimulus effects of nicotine. Exp Clin Psychopharmacol. 2020 Oct 29;. doi: 10.1037/pha0000433. [Epub ahead of print] PubMed PMID: 33119384; PubMed Central PMCID: PMC8406437.
Perkins KA, Karelitz JL. A Forced-Choice Procedure to Assess the Acute Relative Reinforcing Effects of Nicotine Dose per se in Humans. Nicotine Tob Res. 2020 Oct 8;22(10):1685-1693. doi: 10.1093/ntr/ntz224. PubMed PMID: 31800053; PubMed Central PMCID: PMC7542652.
Shoaib M, Perkins KA. Preclinical and clinical research on the discriminative stimulus effects of nicotine. Neuropharmacology. 2020 Jun 15;170:108063. doi: 10.1016/j.neuropharm.2020.108063. Epub 2020 Mar 24. Review. PubMed PMID: 32220607.
Perkins KA, Karelitz JL. Differences in acute reinforcement across reduced nicotine content cigarettes. Psychopharmacology (Berl). 2020 Jun;237(6):1885-1891. doi: 10.1007/s00213-020-05509-9. Epub 2020 Mar 27. PubMed PMID: 32221696; PubMed Central PMCID: PMC7244375.
Perkins KA, Karelitz JL, Boldry MC. Reinforcement Enhancing Effects of Nicotine Via Patch and Nasal Spray. Nicotine Tob Res. 2019 May 21;21(6):778-783. doi: 10.1093/ntr/nty038. PubMed PMID: 29514317; PubMed Central PMCID: PMC6528149.
Perkins KA, Karelitz JL. Acute perceptions of preferred cigarettes when blinded to brand. Tob Control. 2019 May;28(3):311-316. doi: 10.1136/tobaccocontrol-2018-054388. Epub 2018 Jul 10. PubMed PMID: 29991640.
Perkins KA, Karelitz JL, Kunkle N. Sex Differences in Subjective Responses To Moderate Versus Very Low Nicotine Content Cigarettes. Nicotine Tob Res. 2018 Sep 4;20(10):1258-1264. doi: 10.1093/ntr/ntx205. PubMed PMID: 29059330; PubMed Central PMCID: PMC6121913.
Karelitz JL, Perkins KA. Tobacco smoking may delay habituation of reinforcer effectiveness in humans. Psychopharmacology (Berl). 2018 Aug;235(8):2315-2321. doi: 10.1007/s00213-018-4927-3. Epub 2018 May 18. PubMed PMID: 29777289; PubMed Central PMCID: PMC6045957.
Perkins KA, Roy Chengappa KN, Karelitz JL, Boldry MC, Michael V, Herb T, Gannon J, Brar J, Ford L, Rassnick S, Brunzell DH. Initial Cross-Over Test of A Positive Allosteric Modulator of Alpha-7 Nicotinic Receptors to Aid Cessation in Smokers With Or Without Schizophrenia. Neuropsychopharmacology. 2018 May;43(6):1334-1342. doi: 10.1038/npp.2017.292. Epub 2017 Nov 29. PubMed PMID: 29185480; PubMed Central PMCID: PMC5916362.
Perkins KA, Karelitz JL, Kunkle N. Evaluation of menthol per se on acute perceptions and behavioral choice of cigarettes differing in nicotine content. J Psychopharmacol. 2018 Mar;32(3):324-331. doi: 10.1177/0269881117742660. Epub 2018 Feb 22. PubMed PMID: 29468937.
Perkins KA, Karelitz JL, Michael VC. Effects of nicotine versus placebo e-cigarette use on symptom relief during initial tobacco abstinence. Exp Clin Psychopharmacol. 2017 Aug;25(4):249-254. doi: 10.1037/pha0000134. Epub 2017 Jun 26. PubMed PMID: 28650184; PubMed Central PMCID: PMC5546939.
Karelitz JL, Michael VC, Perkins KA. ANALYSIS OF AGREEMENT BETWEEN EXPIRED-AIR CARBON MONOXIDE MONITORS. J Smok Cessat. 2017 Jun;12(2):105-112. doi: 10.1017/jsc.2015.18. Epub 2016 Feb 2. PubMed PMID: 29276544; PubMed Central PMCID: PMC5737632.
Perkins KA, Kunkle N, Karelitz JL, Perkins KA, Kunkle N, Karelitz JL. Preliminary test of cigarette nicotine discrimination threshold in non-dependent versus dependent smokers. Drug Alcohol Depend. 2017 Jun 1;175:36-41. doi: 10.1016/j.drugalcdep.2017.01.033. Epub 2017 Mar 23. PubMed PMID: 28380366; PubMed Central PMCID: PMC5480896.
Perkins KA, Karelitz JL, Boldry MC. Nicotine Acutely Enhances Reinforcement from Non-Drug Rewards in Humans. Front Psychiatry. 2017;8:65. doi: 10.3389/fpsyt.2017.00065. eCollection 2017. Review. PubMed PMID: 28507522; PubMed Central PMCID: PMC5410601.
Karelitz J, Boldry M, Perkins KA. Karelitz, J.L, Michael, V.C., Boldry, M.A., & Perkins, K.A. Validating use of internet-submitted carbon monoxide values by video to determine quit status. Nicotine and Tobacco Research. 2017; 19(11):990-993. doi: 10.1093/ntr/ntw311.
Perkins KA, Kunkle NN, Karelitz JL. Threshold dose for behavioral discrimination of cigarette nicotine content in menthol vs. non-menthol smokers. Psychopharmacology. 2017; 234:1255.
Perkins KA, Karelitz JL. Potential sex differences in the pattern of sensory reinforcers enhanced by nicotine. Exp Clin Psychopharmacol. 2016 Jun;24(3):156-61. doi: 10.1037/pha0000073. Epub 2016 Apr 28. PubMed PMID: 27124265; PubMed Central PMCID: PMC4891248.
Perkins KA, Karelitz JL, Michael VC. Reinforcement enhancing effects of acute nicotine via electronic cigarettes. Drug Alcohol Depend. 2015 Aug 1;153:104-8. doi: 10.1016/j.drugalcdep.2015.05.041. Epub 2015 Jun 6. PubMed PMID: 26070455; PubMed Central PMCID: PMC4509912.
Conklin CA, Vella EJ, Joyce CJ, Salkeld RP, Perkins KA, Parzynski CS. Examining the relationship between cue-induced craving and actual smoking. Exp Clin Psychopharmacol. 2015 Apr;23(2):90-6. doi: 10.1037/a0038826. Epub 2015 Mar 2. PubMed PMID: 25730416; PubMed Central PMCID: PMC4412312.
Forrest PE, Brinson AJ, Gannon JM, George TP, Perkins KA, Chengappa KN. An association between the use of hypnotics and quit status in the treatment of nicotine dependence with varenicline in bipolar disorder. J Clin Psychopharmacol. 2015 Apr;35(2):199-200. doi: 10.1097/JCP.0000000000000272. PubMed PMID: 25627075; PubMed Central PMCID: PMC4344405.
Perkins KA, Karelitz JL. Sex differences in acute relief of abstinence-induced withdrawal and negative affect due to nicotine content in cigarettes. Nicotine Tob Res. 2015 Apr;17(4):443-8. doi: 10.1093/ntr/ntu150. PubMed PMID: 25762754; PubMed Central PMCID: PMC4425834.
Perkins KA, Karelitz JL. Sensory reinforcement-enhancing effects of nicotine via smoking. Exp Clin Psychopharmacol. 2014 Dec;22(6):511-6. doi: 10.1037/a0037823. Epub 2014 Sep 1. PubMed PMID: 25180451; PubMed Central PMCID: PMC4250279.
Perkins KA. Improving efficiency of initial tests for efficacy in smoking cessation drug discovery. Expert Opin Drug Discov. 2014 Nov;9(11):1259-64. doi: 10.1517/17460441.2014.951632. Epub 2014 Aug 20. Review. PubMed PMID: 25138487.
Chengappa KN, Perkins KA, Brar JS, Schlicht PJ, Turkin SR, Hetrick ML, Levine MD, George TP. Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2014 Jul;75(7):765-72. doi: 10.4088/JCP.13m08756. PubMed PMID: 25006684.
Perkins KA, Lerman C. An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation. Psychopharmacology (Berl). 2014 Jan;231(1):1-11. doi: 10.1007/s00213-013-3364-6. Epub 2013 Dec 3. Review. PubMed PMID: 24297304; PubMed Central PMCID: PMC3910509.
Conklin CA, Salkeld RP, Perkins KA, Robin N. Do people serve as cues to smoke?. Nicotine Tob Res. 2013 Dec;15(12):2081-7. doi: 10.1093/ntr/ntt104. Epub 2013 Jul 19. PubMed PMID: 23873978; PubMed Central PMCID: PMC3819981.
Perkins KA, Karelitz JL. Influence of reinforcer magnitude and nicotine amount on smoking's acute reinforcement enhancing effects. Drug Alcohol Depend. 2013 Nov 1;133(1):167-71. doi: 10.1016/j.drugalcdep.2013.05.016. Epub 2013 Jun 13. PubMed PMID: 23768842; PubMed Central PMCID: PMC3786025.
Perkins KA, Lerman C, Karelitz JL, Jao NC, Chengappa KN, Sparks GM. Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications. Addiction. 2013 Nov;108(11):1962-8. doi: 10.1111/add.12273. Epub 2013 Jul 12. PubMed PMID: 23773319; PubMed Central PMCID: PMC3797155.
Perkins KA, Karelitz JL, Jao NC, Gur RC, Lerman C. Effects of bupropion on cognitive performance during initial tobacco abstinence. Drug Alcohol Depend. 2013 Nov 1;133(1):283-6. doi: 10.1016/j.drugalcdep.2013.05.003. Epub 2013 May 31. PubMed PMID: 23726977; PubMed Central PMCID: PMC3786016.
Perkins KA, Jao NC, Karelitz JL. Consistency of daily cigarette smoking amount in dependent adults. Psychol Addict Behav. 2013 Sep;27(3):723-9. doi: 10.1037/a0030287. Epub 2012 Oct 22. PubMed PMID: 23088404; PubMed Central PMCID: PMC3822912.
Perkins KA, Karelitz JL. Reinforcement enhancing effects of nicotine via smoking. Psychopharmacology (Berl). 2013 Aug;228(3):479-86. doi: 10.1007/s00213-013-3054-4. Epub 2013 Mar 15. PubMed PMID: 23494236; PubMed Central PMCID: PMC3707934.
Ashare RL, Wileyto EP, Perkins KA, Schnoll RA. The first 7 days of a quit attempt predicts relapse: validation of a measure for screening medications for nicotine dependence. J Addict Med. 2013 Jul-Aug;7(4):249-54. doi: 10.1097/ADM.0b013e31829363e1. PubMed PMID: 23669629; PubMed Central PMCID: PMC3737394.
Perkins KA, Karelitz JL, Jao NC, Stratton E. Possible reinforcement enhancing effects of bupropion during initial smoking abstinence. Nicotine Tob Res. 2013 Jun;15(6):1141-5. doi: 10.1093/ntr/nts224. Epub 2012 Oct 24. PubMed PMID: 23100457; PubMed Central PMCID: PMC3646646.
Perkins KA, Karelitz JL, Jao NC. Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence. Nicotine Tob Res. 2013 May;15(5):978-82. doi: 10.1093/ntr/nts205. Epub 2012 Sep 18. PubMed PMID: 22990219; PubMed Central PMCID: PMC3733388.
Styn MA, Nukui T, Romkes M, Perkins KA, Land SR, Weissfeld JL. CYP2A6 genotype and smoking behavior in current smokers screened for lung cancer. Subst Use Misuse. 2013 May;48(7):490-4. doi: 10.3109/10826084.2013.778280. Epub 2013 Mar 25. PubMed PMID: 23528144; PubMed Central PMCID: PMC3788637.
Zacny JP, Apfelbaum SM, Perkins KA. Modulating roles of smoking status and sex on oxycodone-induced nausea and drug liking. Exp Clin Psychopharmacol. 2013 Apr;21(2):103-11. doi: 10.1037/a0031706. Epub 2013 Feb 18. PubMed PMID: 23421355.
Perkins KA, Karelitz JL, Giedgowd GE, Conklin CA. Negative mood effects on craving to smoke in women versus men. Addict Behav. 2013 Feb;38(2):1527-1531. doi: 10.1016/j.addbeh.2012.06.002. Epub 2012 Jun 7. PubMed PMID: 22726579; PubMed Central PMCID: PMC3462895.
Levine MD, Cheng Y, Kalarchian MA, Perkins KA, Marcus MD. Dietary intake after smoking cessation among weight-concerned women smokers. Psychol Addict Behav. 2012 Dec;26(4):969-73. doi: 10.1037/a0028948. Epub 2012 Jul 16. PubMed PMID: 22799893; PubMed Central PMCID: PMC3475794.
Conklin CA, Parzynski CS, Salkeld RP, Perkins KA, Fonte CA. Cue reactivity as a predictor of successful abstinence initiation among adult smokers. Exp Clin Psychopharmacol. 2012 Dec;20(6):473-8. doi: 10.1037/a0029599. Epub 2012 Aug 13. PubMed PMID: 22889039; PubMed Central PMCID: PMC3752834.
Perkins KA, Giedgowd GE, Karelitz JL, Conklin CA, Lerman C. Smoking in response to negative mood in men versus women as a function of distress tolerance. Nicotine Tob Res. 2012 Dec;14(12):1418-25. doi: 10.1093/ntr/nts075. Epub 2012 Mar 13. PubMed PMID: 22416115; PubMed Central PMCID: PMC3509012.
Perkins KA, Karelitz JL, Giedgowd GE, Conklin CA. The reliability of puff topography and subjective responses during ad lib smoking of a single cigarette. Nicotine Tob Res. 2012 Apr;14(4):490-4. doi: 10.1093/ntr/ntr150. Epub 2011 Oct 29. PubMed PMID: 22039077; PubMed Central PMCID: PMC3313780.
Perkins KA, Giedgowd GE, Karelitz JL, Conklin CA, Parzynski CS. Expectancy for negative affect relief due to smoking may not be predictive under acute mood situations. Exp Clin Psychopharmacol. 2012 Apr;20(2):161-6. doi: 10.1037/a0026456. Epub 2011 Dec 5. PubMed PMID: 22141336.
Perkins KA. Subjective reactivity to smoking cues as a predictor of quitting success. Nicotine Tob Res. 2012 Apr;14(4):383-7. doi: 10.1093/ntr/ntr229. Epub 2011 Dec 1. PubMed PMID: 22140145; PubMed Central PMCID: PMC3313783.
Perkins KA, Parzynski C, Mercincavage M, Conklin CA, Fonte CA. Is self-efficacy for smoking abstinence a cause of, or a reflection on, smoking behavior change?. Exp Clin Psychopharmacol. 2012 Feb;20(1):56-62. doi: 10.1037/a0025482. Epub 2011 Sep 12. PubMed PMID: 21910550; PubMed Central PMCID: PMC3731142.
Perkins KA, Pershad S, Chen Q, McGraw S, Adams JS, Zambrano C, Krass S, Emrich J, Bell B, Iyamu M, Prince C, Kay H, Teng JC, Young LH. The effects of modulating eNOS activity and coupling in ischemia/reperfusion (I/R). Naunyn Schmiedebergs Arch Pharmacol. 2012 Jan;385(1):27-38. doi: 10.1007/s00210-011-0693-z. Epub 2011 Sep 25. PubMed PMID: 21947254.
Lee DC, Perkins KA, Zimmerman E, Robbins G, Kelly TH. Effects of 24 hours of tobacco withdrawal and subsequent tobacco smoking among low and high sensation seekers. Nicotine Tob Res. 2011 Oct;13(10):943-54. doi: 10.1093/ntr/ntr102. Epub 2011 Jun 20. PubMed PMID: 21690318; PubMed Central PMCID: PMC3179670.
Okun ML, Levine MD, Houck P, Perkins KA, Marcus MD. Subjective sleep disturbance during a smoking cessation program: associations with relapse. Addict Behav. 2011 Aug;36(8):861-4. doi: 10.1016/j.addbeh.2011.03.001. Epub 2011 Mar 9. PubMed PMID: 21482029; PubMed Central PMCID: PMC3588159.
Perkins KA, Lerman C. Early human screening of medications to treat drug addiction: novel paradigms and the relevance of pharmacogenetics. Clin Pharmacol Ther. 2011 Mar;89(3):460-3. doi: 10.1038/clpt.2010.254. Epub 2011 Jan 26. PubMed PMID: 21270792; PubMed Central PMCID: PMC3188428.
What would you like to do?